TFCP2L1-IN-1
TFCP2L1-IN-1 is a specific small molecule targeting TFCP2L1’s active domain with anti-cancer activity. TFCP2L1-IN-1 synergizes with Sorafenib to induce Apoptosis and reduces cell proliferation, invasion, metastasis, clonal formation and sphere-forming capacity in hepatocellular carcinoma cells[1].
Product Specifications
CAS Number
364621-46-5
UNSPSC
12352211
Target
Apoptosis; Connective Peptide
Type
Reference compound
Related Pathways
Apoptosis; Stem Cell/Wnt
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tfcp2l1-in-1.html
Concentration
10mM
Purity
99.66
Solubility
DMSO : 175 mg/mL (ultrasonic)
Smiles
BrC1=CC=CC(C(NC(NC2=CC=CC=C2C)=S)=O)=C1
Molecular Formula
C15H13BrN2OS
Molecular Weight
349.25
References & Citations
[1]Qiu D, et al. TFCP2L1 drives stemness and enhances their resistance to Sorafenib treatment by modulating the NANOG/STAT3 pathway in hepatocellular carcinoma. Oncogenesis. 2024 Sep 12;13 (1) :33.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
TFCP2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC426199 20 µg
FAM70A (TMEM255A) (NM_001104544) Human Over-expression Lysate
Sign In for Pricing
View Details 
E-UNEL-R0034-01 5x 96 Tests
Uncoated Rat gp130 (Glucoprotein 130) ELISA Kit
Sign In for Pricing
View Details E-UNEL-R0034-02 15x 96 Tests
Uncoated Rat gp130 (Glucoprotein 130) ELISA Kit
Sign In for Pricing
View Details 
LY422275 100 µg
METT11D1 (METTL17) (NM_001029991) Human Over-expression Lysate
Sign In for Pricing
View Details